Differential VIP and VIP1 receptor gene expression in rat thymocyte subsets

Peptides

Volumn 17, Issue 5, 1996, Pages 803-807

  Delgado, M ^a   Martinez C ^a   Leceta, J ^a   Garrido, E ^a   Gomariz, Rosa P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Gene expression; Thymocytes; VIP; VIP1 receptor

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MESSENGER RNA; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; PRIMER DNA;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION; THYMOCYTE; ANIMAL; BIOSYNTHESIS; CD4 CD8 RATIO; CHEMISTRY; CYTOLOGY; GENETICS; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; T LYMPHOCYTE SUBPOPULATION; THYMUS; WISTAR RAT;

ANIMALIA;

ANIMALS; BASE SEQUENCE; CD4-CD8 RATIO; DNA PRIMERS; GENE EXPRESSION; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0029658003     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00070-8     Document Type: Article

References (26)

1. 1. Bellinger, D. L.; Lorton, D.; Romano, T. D.; Olschowka, J. A.; Felten, S. Y.; Felten, D. L. Neuropeptides and immunopeptides. Ann. NY Acad. Sci. 594:17-33; 1990.
2. 2. Besedovsky, H.; Del Rey, A. Immune-neuroendocrine circuits: Integrative role of cytokines. Front. Neuroendocrinol. 13:61-94; 1992.
3. 3. Blalock, J. E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol. Rev. 69:1-32; 1989.
4. 4. Blalock, J. E. The syntax of immune-neuroendocrine communication. Immunol. Today 15:504-511; 1994.
5. 5. Boudard, F.; Bastide, M. Inhibition of mouse T cell proliferation by CGRP and VIP: Effects of these neuropeptides on IL-2 production and cAMP synthesis. J. Neurosci. Res. 29:29-41; 1991.
6. 6. Calvo, J. R.; Molinero, P.; Jiménez, J.; Goberna, R.; Guerrero, J. M. Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells. Peptides 7:177-181; 1986.
7. 7. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Ann. Biochem. 162:156-159; 1987.
8. 8. Dardenne, M.; Savino, W. Control of thymus physiology by peptidic hormones and neuropeptides. Immunol. Today 15:518-523; 1994.
9. - thymocytes from glucocorticoid-induced apoptosis. Blood 87; 1996.
10. 10. Geenen, V.; Cormann-Goffin, N.; Martens, H.; Vardermissen, E.; Robert, F.; Benhida, A.; Legros, J. J.; Martial, J.; Franchimont, P. Thymic neurohypophysial related peptides and T cell selection. Regul. Pept. 45:273-278; 1993.
11. 11. Godfrey, D. I.; Zlonik, A. Control points in early T-cell development. Immunol. Today 14:547-553; 1993.
12. 12. Gomariz, R. P.; Leceta, J.; Garrido, E.; Garrido, T.; Delgado, M. Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes. Regul. Pept. 50:177-184; 1994.
13. 13. Gomariz, R. P.; Garrido, E.; Leceta, J.; Martínez, M. C.; Abalo, R.; Delgado, M. Gene expression of VIP receptor in rat lymphocytes. Biochem. Biophys. Res. Commun. 203:1599-1604; 1994.
14. 14. Ishihara, T.; Shigemoto, R.; Mori, K.; Takahashi, K.; Nagata, S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819; 1992.
15. 15. Ishioka, C.; Yoshida, A.; Kimata, H.; Mikawa, H. Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells. Clin. Exp. Immunol. 87:504-508; 1992.
16. 16. Lutz, E. M.; Sheward, W. J.; West, K. M.; Morrow, J. A.; Fink, G.; Harmar, A. J. The VIP 2 receptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334:3-8; 1993.
17. 17. O'Neil, K. D.; Montgomery, D. W.; Truong, T. M.; Yu-Lee, L. Y. Prolactin gene expression in human thymocytes. Mol. Cell. Endocrinol. 87:R19-R23; 1992.
18. 18. Ottaway, C. A. In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T-cells. J. Exp. Med. 160:1054-1069; 1984.
19. 19. Ottaway, C. A.; Greenberg, G. R. Interaction of vasoactive intestinal peptide with mouse lymphocytes: Specific binding and the modulation of mitogen responses. J. Immunol. 132:417-423; 1984.
20. 20. Rola-Pleszczynski, M. R.; Bolduc, D.; St.Pierre, S. The effect of vasoactive intestinal peptide on human natural killer cell function. J. Immunol. 135:2569-2573; 1985.
21. 21. Rosen, H.; Behar, O.; Abramsky, O.; Ovadia, D. Regulated expression of proenkephalin A in normal lymphocytes. J. Immunol. 143:3703-3707; 1989.
22. 22. Santambrogio, L.; Benedetti, M.; Chao, M. V.; Muzaffar, R.; Kulig, K.; Gabellini, N.; Hochwald, G. Nerve growth factor production by lymphocytes. J. Immunol. 153:4488-4495; 1994.
23. 23. Sun, L.; Ganea, D. Vasoactive intestinal peptide inhibits interleukin IL-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex. J. Neuroimmunol. 48:59-70; 1993.
24. 24. Usdin, T. B.; Bonner, T. I.; Mezey, E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135:2662-2680; 1994.
25. 25. Vacchio, M. S.; Papadopoulos, V.; Ashwell, J. D. Steroid production in the thymus: Implication for thymocyte selection. J. Exp. Med. 179:1835-1846; 1994.
26. 26. Xin, Z.; Tang, H.; Ganea, D. Vasoactive intestinal peptide inhibits interleukin IL-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J. Neuroimmunol. 54:59-68; 1994.